6/26/2025

IQVIA’s first quarter performance reflected steady execution against a complex industry backdrop, with revenue and adjusted earnings per share both coming in ahead of Wall Street’s expectations. Management credited the quarter’s results to robust demand in its Technology & Analytics Solutions segment, particularly double-digit growth in real-world evidence services. CEO Ari Bousbib emphasized that pent-up demand from previously delayed projects and the need to support new drug launches drove thi

Source: Yahoo

6/26/2025

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will it work? And will biotech stocks take a hit?

Source: Yahoo

6/24/2025

IQVIA Holdings Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

6/24/2025

Calamos Phineus Long/Short Fund rose 0.93% in Q1 (Class I shares at NAV), compared with a price decline of -4.27% for the S&P 500 Index and loss of -2.15% for the MSCI World Index.

Source: SeekingAlpha

6/23/2025

Presenter SpeechTodd Culpepper Welcome to today's webinar on Pathways to Overcome Challenges to CAR T-cell Therapy Health System Readiness. I'm Todd Culpepper with the IQVIA Institute, and we're

Source: Finnhub

6/18/2025

This is our monthly dashboard series on Healthcare and Pharma stocks. Read the full analysis here, and which 10 healthcare stocks were cheaper than their peers in June 2025.

Source: SeekingAlpha

6/18/2025

Veeva Systems' accelerating growth, AI launch, and strong margins support a 20% CAGR estimate. Click here for a full investment analysis of VEEV stock.

Source: SeekingAlpha

6/17/2025

IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors

Source: MarketWatch

6/17/2025

Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc.VANCOUVER, BC, June 17, 2025 /PRNewswire/ -- Venture Capital continues to flow in bunches into the AI in healthcare sector,...

Source: Finnhub

6/17/2025

RESEARCH TRIANGLE PARK, N.C. - IQVIA , a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been...

Source: Finnhub

6/17/2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest of the drug development inputs & services stocks fared in Q1.

Source: Yahoo

6/16/2025

RESEARCH TRIANGLE PARK, N.C., June 16, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been selected as the winner of the "Best Mobile App for Patient Engagement" in the ninth-annual MedTech Breakthrough Awards program.

Source: Yahoo

6/15/2025

Harris Associates' Q1 2025 portfolio shifts reveal major stake changes in top stocks like ConocoPhillips and Airbnb.

Source: SeekingAlpha

6/13/2025

IQVIA Holdings Inc. stock underperforms Friday when compared to competitors

Source: MarketWatch

6/11/2025

RESEARCH TRIANGLE PARK, N.C., June 11, 2025--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, unveils AI agents at GTC Paris. IQVIA’s new custom-built AI agents using NVIDIA technology are designed to enhance workflows and accelerate insights for life sciences. These live applications of agentic architectures illustrate how IQVIA AI and deep domain expertise are transforming

Source: Yahoo

6/10/2025

IQVIA Holdings (NYSE:IQV) experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade...

Source: Yahoo

6/5/2025

DOCS slips 4.4% in a month despite strong Q4 results, margin gains and raised guidance -- is there a buying opportunity?

Source: Yahoo

6/5/2025

Veeva Systems' strong Q1 FY2026 results highlight AI innovation and industry expertise. Click to read my full analysis of the VEEV stock.

Source: SeekingAlpha

6/5/2025

Let’s dig into the relative performance of Repligen (NASDAQ:RGEN) and its peers as we unravel the now-completed Q1 drug development inputs & services earnings season.

Source: Yahoo

6/2/2025

RESEARCH TRIANGLE PARK, N.C., June 02, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the "Issuer"), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2032 (the "Notes"). The proceeds from the Notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering, with any excess proceeds used for other genera

Source: Yahoo